Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network

Abstract The objectives of our study were to assess retention rate, safety, and predictive factors for retention of subcutaneous (SC) TNF inhibitors (TNFi) (adalimumab (ADA), etanercept (ETN), golimumab (GOL), and certolizumab pegol (CZP)) in axial spondyloarthritis (axSpA) depending on the line of...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Guillaume Larid, Guy Baudens, Georges Tiemdjo-Djimaffo, Pascal Coquerelle, Vincent Goeb, Marie Hélène Guyot, Laurent Marguerie, Frédéric Maury, Eric Veillard, Eric Houvenagel, Jean-Hugues Salmon, René-Marc Flipo, Elisabeth Gervais
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Nature Portfolio 2024-01-01
Saila:	Scientific Reports
Sarrera elektronikoa:	https://doi.org/10.1038/s41598-024-52016-4
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!